UNIKORNプログラム特別イベント A global perspective for Japanese startups～日本のスタートアップの飛躍に向けた、グローバルメンターからの洞察～

Philippe Fauchet OBE, Venture Partner, 4BIO Capital （Former GM at GSK Japan）

He is the founder of Mirasense Partners, a provider of consulting services for Life Sciences Companies. 
He is also a Venture Partner at 4BioCapital investment fund (UK) and an External Director on the Board of Biotech companies in Japan and in the USA.
He is a Director on the Board of MEJ (Medical Excellence Japan), a public-private partnership.                
Philippe serves as Senior Advisor to EFPIA, having been the Chairman of the association previously. 
Philippe is also appointed French Foreign Trade Honorary Advisor (CCE).
He has been Adjunct Professor at the University of Tokyo, Graduate School of Medicine, Global Health Policy Department and an Affiliate Senior Research Fellow of the Tokyo Foundation for Policy Research.

He graduated from Hautes Études Commerciales (HEC) in France and obtained a Bachelor of Law from Paris University

He was awarded Honorary Officer of the Most Excellent Order of the British Empire (O.B.E.) in 2014.

James Feliciano, President and Founder, 3C Advisors GK（Former President, AbbVie Japan）

James Feliciano is the President of 3C Advisors GK, a Tokyo-based strategic advisory and executive coaching firm focused on healthcare and innovation. With over 25 years of experience leading global pharmaceutical businesses, James has held executive roles at Fortune 100 companies, where he built high-performing organizations, launched market-leading products, and drove commercial success in complex, highly regulated markets.

At 3C Advisors, he partners with startups, investors, and corporates across Japan, the U.S., and Europe—offering advisory support on market entry, organizational build-out, and go-to-market strategy. James is also a certified executive coach (ICF ACC) and a member of the Marshall Goldsmith 100 Coaches community, working with founders and leaders on leadership presence, stakeholder influence, and team development.

As a venture partner at Saisei Ventures, James brings his cross-cultural fluency and operator experience to support early-stage biotech startups navigating the Japan–global bridge. He is especially passionate about enabling Japanese innovation to scale globally through thoughtful leadership, strategic clarity, and investor readiness.